113 related articles for article (PubMed ID: 16885347)
1. MLH3 mutation in endometrial cancer.
Taylor NP; Powell MA; Gibb RK; Rader JS; Huettner PC; Thibodeau SN; Mutch DG; Goodfellow PJ
Cancer Res; 2006 Aug; 66(15):7502-8. PubMed ID: 16885347
[TBL] [Abstract][Full Text] [Related]
2. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers.
Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS
Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354
[TBL] [Abstract][Full Text] [Related]
3. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
[TBL] [Abstract][Full Text] [Related]
4. The first functional study of MLH3 mutations found in cancer patients.
Korhonen MK; Vuorenmaa E; Nyström M
Genes Chromosomes Cancer; 2008 Sep; 47(9):803-9. PubMed ID: 18521850
[TBL] [Abstract][Full Text] [Related]
5. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
[TBL] [Abstract][Full Text] [Related]
6. Germline and somatic mutation analysis of MLH3 in MSI-positive colorectal cancer.
Loukola A; Vilkki S; Singh J; Launonen V; Aaltonen LA
Am J Pathol; 2000 Aug; 157(2):347-52. PubMed ID: 10934138
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers.
Goodfellow PJ; Buttin BM; Herzog TJ; Rader JS; Gibb RK; Swisher E; Look K; Walls KC; Fan MY; Mutch DG
Proc Natl Acad Sci U S A; 2003 May; 100(10):5908-13. PubMed ID: 12732731
[TBL] [Abstract][Full Text] [Related]
8. Little evidence for involvement of MLH3 in colorectal cancer predisposition.
Hienonen T; Laiho P; Salovaara R; Mecklin JP; Järvinen H; Sistonen P; Peltomäki P; Lehtonen R; Nupponen NN; Launonen V; Karhu A; Aaltonen LA
Int J Cancer; 2003 Aug; 106(2):292-6. PubMed ID: 12800209
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations in mismatch repair genes in sporadic gastric carcinomas are not a cause but a consequence of the mutator phenotype.
Pinto M; Wu Y; Mensink RG; Cirnes L; Seruca R; Hofstra RM
Cancer Genet Cytogenet; 2008 Jan; 180(2):110-4. PubMed ID: 18206535
[TBL] [Abstract][Full Text] [Related]
10. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers.
Zhang J; Lindroos A; Ollila S; Russell A; Marra G; Mueller H; Peltomaki P; Plasilova M; Heinimann K
Cancer Res; 2006 Jan; 66(2):659-64. PubMed ID: 16423994
[TBL] [Abstract][Full Text] [Related]
11. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
[TBL] [Abstract][Full Text] [Related]
12. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
13. A role for MLH3 in hereditary nonpolyposis colorectal cancer.
Wu Y; Berends MJ; Sijmons RH; Mensink RG; Verlind E; Kooi KA; van der Sluis T; Kempinga C; van dDer Zee AG; Hollema H; Buys CH; Kleibeuker JH; Hofstra RM
Nat Genet; 2001 Oct; 29(2):137-8. PubMed ID: 11586295
[TBL] [Abstract][Full Text] [Related]
14. Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability.
Kuismanen SA; Moisio AL; Schweizer P; Truninger K; Salovaara R; Arola J; Butzow R; Jiricny J; Nyström-Lahti M; Peltomäki P
Am J Pathol; 2002 Jun; 160(6):1953-8. PubMed ID: 12057899
[TBL] [Abstract][Full Text] [Related]
15. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
[TBL] [Abstract][Full Text] [Related]
16. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome.
Ou J; Rasmussen M; Westers H; Andersen SD; Jager PO; Kooi KA; Niessen RC; Eggen BJ; Nielsen FC; Kleibeuker JH; Sijmons RH; Rasmussen LJ; Hofstra RM
Genes Chromosomes Cancer; 2009 Apr; 48(4):340-50. PubMed ID: 19156873
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden.
Cederquist K; Emanuelsson M; Göransson I; Holinski-Feder E; Müller-Koch Y; Golovleva I; Grönberg H
Int J Cancer; 2004 Apr; 109(3):370-6. PubMed ID: 14961575
[TBL] [Abstract][Full Text] [Related]
19. Causes and consequences of microsatellite instability in endometrial carcinoma.
Gurin CC; Federici MG; Kang L; Boyd J
Cancer Res; 1999 Jan; 59(2):462-6. PubMed ID: 9927063
[TBL] [Abstract][Full Text] [Related]
20. MSI in endometrial carcinoma: absence of MLH1 promoter methylation is associated with increased familial risk for cancers.
Whelan AJ; Babb S; Mutch DG; Rader J; Herzog TJ; Todd C; Ivanovich JL; Goodfellow PJ
Int J Cancer; 2002 Jun; 99(5):697-704. PubMed ID: 12115503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
